National Comprehensive Cancer Network



About NCCN

Colon/Rectal/Anal Cancers Panel - Disclosures as of 10/19/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Tanios Bekaii-Saab, MD

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

Al B. Benson III, MD, FACP, FASCO

None

Agendia BV;
Bayer HealthCare;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
National Cancer Institute;
Precision Therapeutics, Inc.

None

None

None

Emily Chan, MD, PhD

None

Amgen Inc.;
Bayer HealthCare

None

None

None

Yi-Jen Chen, MD, PhD

None

None

None

None

None

Michael A. Choti, MD, MBA

None

Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

None

Harry S. Cooper, MD

None

None

None

None

None

Paul F. Engstrom, MD, FACP

None

None

None

None

None

Peter C. Enzinger, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

None

Marwan G Fakih, MD

None

None

None

None

None

Moon Fenton, MD, PhD

None

None

None

None

None

Deborah Freedman-Cass, PhD

None

None

None

None

None

Charles S. Fuchs, MD, MPH

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
ImClone Systems Incorporated;
Infinity Pharmaceuticals;
Metamark Genetics;
Momenta Pharmaceuticals;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Jean L. Grem, MD

None

Adherex Technologies Inc.

None

None

None

Steven Hunt, MD

None

None

None

None

None

Ahmed Kamel, MD

None

None

None

None

None

Lucille A. Leong, MD

None

None

None

None

None

Edward Lin, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Schering-Plough Corporation

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Mary F. Mulcahy, MD

None

None

None

None

None

Eric Rohren, MD, PhD

None

None

None

None

None

David P. Ryan, MD

None

Human Genome Sciences, Inc.

None

None

None

Kilian E. Salerno, MD

None

None

None

None

None

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Taiho Parmaceuticals Co., Ltd.

None

None

None

Sunil Sharma, MD

None

None

None

None

None

David Shibata, MD

None

None

None

None

None

John M. Skibber, MD

None

None

None

None

None

William Small, MD

None

None

None

None

None

Constantinos T. Sofocleous, MD, PhD, FSIR, FCIRSE

None

Sirtex Medical Inc

None

None

None

Alan P. Venook, MD

None

Abbott Laboratories;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

Christopher G. Willett, MD

None

None

None

None

None